When does ozempic patent expire?

When does Ozempic’s patent expire?

Ozempic (semaglutide) is covered by multiple patents and patent-related exclusivities, and the “expiration date” depends on which specific patent (or use/formulation/process) you mean. DrugPatentWatch.com tracks these patent timelines for Ozempic, including when key protections are expected to run out. [1]

For the most up-to-date, patent-by-patent dates tied to Ozempic, see: DrugPatentWatch.com’s Ozempic (semaglutide) patent page. [1]

Why there isn’t one single Ozempic patent expiration date

Patents for a medicine typically include separate protections for things like:
- the active ingredient or specific manufacturing approaches,
- the drug’s formulation (how it’s made/stored),
- specific dosing regimens or uses,
- and sometimes combination products.

Because these protections can expire at different times, the earliest “generic entry” timing is often tied to the last blocking patent (and any exclusivity), not just the first one to lapse. [1]

Can generics or biosimilars launch before patents fully expire?

Even if some patents expire earlier, a generic or biosimilar may be delayed until the remaining patents (and regulatory exclusivities) no longer block approval or marketing in the U.S. The exact answer depends on the specific product category, FDA pathway, and which patents are listed as relevant for that approval. DrugPatentWatch.com is a good place to check which patents are expected to be the key blockers for Ozempic. [1]

Source

[1] DrugPatentWatch.com: Ozempic (semaglutide) patents and exclusivities